论文信息 - Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report. - 字舞流文

Imatinib and Dasatinib-induced Ulcerative Colitis: Case Report.

V. Villanacci | G. Bassotti | R. Del Sordo | G. Lupinacci | G. Tanzi

[1] D. Tan,et al. An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia. , 2020, Inflammatory bowel diseases.

[2] P. Katelaris,et al. Dasatinib-induced colitis: a case report. , 2019, Pathology.

[3] B. Nørgård,et al. Increased risk of developing Crohn’s disease or ulcerative colitis in 17 018 patients while under treatment with anti‐TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease , 2019, Alimentary pharmacology & therapeutics.

[4] G. Can,et al. The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. , 2016, Clinics and research in hepatology and gastroenterology.

[5] Jason D. Eckmann,et al. De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.